Reinhold Kerb

8.6k total citations
69 papers, 6.7k citations indexed

About

Reinhold Kerb is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Reinhold Kerb has authored 69 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 21 papers in Pediatrics, Perinatology and Child Health and 20 papers in Pharmacology. Recurrent topics in Reinhold Kerb's work include Drug Transport and Resistance Mechanisms (29 papers), Pharmacogenetics and Drug Metabolism (17 papers) and Pharmacological Effects and Toxicity Studies (17 papers). Reinhold Kerb is often cited by papers focused on Drug Transport and Resistance Mechanisms (29 papers), Pharmacogenetics and Drug Metabolism (17 papers) and Pharmacological Effects and Toxicity Studies (17 papers). Reinhold Kerb collaborates with scholars based in Germany, United States and Switzerland. Reinhold Kerb's co-authors include Ivar Roots, Ulrich Brinkmann, Jürgen Brockmöller, Matthias Schwab, Thomas Lang, Elke Schaeffeler, Ingolf Cascorbi, Michel Eichelbaum, Céline Verstuyft and Laurent Becquemont and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Hepatology.

In The Last Decade

Reinhold Kerb

69 papers receiving 6.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Reinhold Kerb Germany 42 3.3k 1.8k 1.8k 1.6k 1.2k 69 6.7k
Satohiro Masuda Japan 49 4.6k 1.4× 2.9k 1.6× 1.9k 1.1× 943 0.6× 1.2k 1.0× 191 8.8k
Toshiyuki Sakaeda Japan 45 2.8k 0.8× 1.4k 0.7× 2.1k 1.2× 974 0.6× 1.0k 0.8× 220 7.1k
Oliver Burk Germany 35 4.5k 1.4× 2.4k 1.3× 1.9k 1.1× 3.4k 2.2× 821 0.7× 68 8.0k
Deanna L. Kroetz United States 46 3.1k 0.9× 1.4k 0.8× 3.1k 1.7× 1.9k 1.2× 655 0.5× 133 8.6k
Elke Schaeffeler Germany 52 3.3k 1.0× 2.0k 1.1× 2.8k 1.6× 1.8k 1.1× 1.4k 1.1× 181 9.6k
Ute Hofmann Germany 45 1.9k 0.6× 983 0.5× 1.7k 0.9× 1.6k 1.0× 743 0.6× 183 6.3k
Toshiya Katsura Japan 49 3.7k 1.1× 2.0k 1.1× 2.4k 1.4× 626 0.4× 698 0.6× 144 7.0k
Chantal Guillemette Canada 50 2.2k 0.7× 1.7k 0.9× 4.0k 2.2× 2.9k 1.9× 557 0.4× 187 8.3k
Kim L. R. Brouwer United States 55 6.0k 1.8× 3.2k 1.7× 1.4k 0.8× 3.4k 2.2× 1.1k 0.9× 279 9.7k
Andreas Johne Germany 23 2.4k 0.7× 1.5k 0.8× 706 0.4× 1.1k 0.7× 442 0.4× 85 4.2k

Countries citing papers authored by Reinhold Kerb

Since Specialization
Citations

This map shows the geographic impact of Reinhold Kerb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reinhold Kerb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reinhold Kerb more than expected).

Fields of papers citing papers by Reinhold Kerb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reinhold Kerb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reinhold Kerb. The network helps show where Reinhold Kerb may publish in the future.

Co-authorship network of co-authors of Reinhold Kerb

This figure shows the co-authorship network connecting the top 25 collaborators of Reinhold Kerb. A scholar is included among the top collaborators of Reinhold Kerb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reinhold Kerb. Reinhold Kerb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heinkele, Georg, et al.. (2020). Stereoselective quantification of phase 1 and 2 metabolites of clomiphene in human plasma and urine. Talanta. 221. 121658–121658. 7 indexed citations
2.
Matthaei, Johannes, Wagner Hugo Bonat, Reinhold Kerb, et al.. (2020). Inherited and Acquired Determinants of Hepatic CYP3A Activity in Humans. Frontiers in Genetics. 11. 944–944. 17 indexed citations
4.
Matthaei, Johannes, Mladen V. Tzvetkov, David Sehrt, et al.. (2016). Heritability of Caffeine Metabolism: Environmental Effects Masking Genetic Effects on CYP1A2 Activity but Not on NAT2. Clinical Pharmacology & Therapeutics. 100(6). 606–616. 25 indexed citations
5.
Lindner, Wolfgang, Michael Lämmerhofer, Georg Heinkele, et al.. (2013). Simultaneous quantification of mefloquine (+)- and (−)-enantiomers and the carboxy metabolite in dried blood spots by liquid chromatography/tandem mass spectrometry. Journal of Chromatography B. 968. 32–39. 20 indexed citations
6.
Porter, Andrew C.G., Dennis Strand, Rachel Brough, et al.. (2012). Functional characterization of protein variants of the human multidrug transporter ABCC2 by a novel targeted expression system in fibrosarcoma cells. Human Mutation. 33(4). 750–762. 18 indexed citations
7.
Nies, Anne T., Hermann Koepsell, Stefan Winter, et al.. (2009). Expression of Organic Cation Transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) Is Affected by Genetic Factors and Cholestasis in Human Liver†. Hepatology. 50(4). 1227–1240. 306 indexed citations
8.
Kerb, Reinhold. (2006). Implications of genetic polymorphisms in drug transporters for pharmacotherapy. Cancer Letters. 234(1). 4–33. 171 indexed citations
9.
Lang, Thomas, Michael Haberl, Diana Jung, et al.. (2006). Genetic Variability, Haplotype Structures, and Ethnic Diversity of Hepatic Transporters MDR3 (ABCB4) and Bile Salt Export Pump (ABCB11). Drug Metabolism and Disposition. 34(9). 1582–1599. 79 indexed citations
10.
Babaoğlu, Melih O., et al.. (2005). Association of the ABCB1 3435C>T polymorphism with antiemetic efficacy of 5-hydroxytryptamine type 3 antagonists. Clinical Pharmacology & Therapeutics. 78(6). 619–626. 58 indexed citations
11.
Noé, Johannes, Gerd A. Kullak‐Ublick, Wolfram Jochum, et al.. (2005). Impaired expression and function of the bile salt export pump due to three novel ABCB11 mutations in intrahepatic cholestasis. Journal of Hepatology. 43(3). 536–543. 95 indexed citations
12.
Lang, Thomas, Monika Hitzl, Oliver Burk, et al.. (2004). Genetic polymorphisms in the multidrug resistance-associated protein 3 (ABCC3, MRP3) gene and relationship to its mRNA and protein expression in human liver. Pharmacogenetics. 14(3). 155–164. 81 indexed citations
13.
Pauli‐Magnus, Christiane, Reinhold Kerb, Karin Fattinger, et al.. (2004). BSEP and MDR3 haplotype structure in healthy Caucasians, primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology. 39(3). 779–791. 124 indexed citations
14.
Eap, Chin B., Thierry Buclin, Daniele Zullino, et al.. (2004). Oral administration of a low dose of midazolam (75�?g) as an in vivo probe for CYP3A activity. European Journal of Clinical Pharmacology. 60(4). 237–46. 84 indexed citations
15.
Dazert, Peter, Konrad Meissner, Silke Vogelgesang, et al.. (2003). Expression and Localization of the Multidrug Resistance Protein 5 (MRP5/ABCC5), a Cellular Export Pump for Cyclic Nucleotides, in Human Heart. American Journal Of Pathology. 163(4). 1567–1577. 78 indexed citations
16.
Johne, Andreas, Karla Köpke, Thomas Gerloff, et al.. (2002). Modulation of steady‐state kinetics of digoxin by haplotypes of the P‐glycoprotein MDR1 gene. Clinical Pharmacology & Therapeutics. 72(5). 584–594. 267 indexed citations
17.
Kerb, Reinhold, et al.. (2002). Influence of GSTT1 and GSTM1 Genotypes on Sunburn Sensitivity. PubMed. 2(2). 147–154. 20 indexed citations
18.
Becquemont, Laurent, Céline Verstuyft, Reinhold Kerb, et al.. (2001). Effect of grapefruit juice on digoxin pharmacokinetics in humans. Clinical Pharmacology & Therapeutics. 70(4). 311–316. 310 indexed citations
19.
Kerb, Reinhold, et al.. (2000). Analysis of Drug Pharmacology towards Predicting Drug Behavior by Expression Profiling Using High‐Density Oligonucleotide Arrays. Annals of the New York Academy of Sciences. 919(1). 9–15. 15 indexed citations
20.
Brockmöller, Jürgen, D. H. E. Gross, Reinhold Kerb, Nikolaos Drakoulis, & Ivar Roots. (1992). Correlation between trans-stilbene oxide-glutathione conjugation activity and the deletion mutation in the glutathione S-transferase class Mu gene detected by polymerase chain reaction. Biochemical Pharmacology. 43(3). 647–650. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026